Biofil Chemicals and Pharmaceuticals share price
You have to be logged in to add this to Watchlist.- ₹39.00(-1.86%)November 14, 2025 15:29:50 PM IST
- NSE
- BSE
- Vol : 3.75K (NSE + BSE)Last 20 day avg : 13.05 K
Biofil Chemicals and Pharmaceuticals is trading -1.86% lower at Rs 39.00 as compared to its last closing price. Biofil Chemicals and Pharmaceuticals has been trading in the price range of 39.67 & 38.91. Biofil Chemicals and Pharmaceuticals has given -31.49% in this year & 1.65% in the last 5 days. Biofil Chemicals and Pharmaceuticals has TTM P/E ratio 27.46 as compared to the sector P/E of 30.99.The company posted a net profit of 2.41 Crores in its last quarter.Listed peers of Biofil Chemicals and Pharmaceuticals include Nutricircle (4.88%), Sunil Healthcare (0.38%), Vivo Bio Tech (0.39%).The Mutual Fund holding in Biofil Chemicals and Pharmaceuticals was at -% in . The MF holding has - from the last quarter. The FII holding in Biofil Chemicals and Pharmaceuticals was at 0.03% in 31 Mar 2024. The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Nov 14, 2025, 08:25 PM UTC
- BetaLow volatility0.63Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.03The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BLower than historical values3.41The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values22.91Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates undervaluation-3.17The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is profitable
The company's revenue fell during June quarter by 23.82% from Rs 8.44 crore to Rs 6.43 crore, year-on-year- The company has grown its June quarter profit by 1324.10% from Rs 0.17 crore to Rs 2.41 crore, year-on-year
- The debt to equity of the company is lower than the industry median
- Company can comfortably pay off its interest obligations with its earnings
- R1
- 41.57
- R2
- 42.44
- R3
- 44.16
- S1
- 38.98
- S2
- 37.26
- S3
- 36.39
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Nutricircle | Neutral | 225.50 | 4.88 | 225.50 | 779.57 | 16.26 | - | 13.87 |
| Sunil Healthcare | Bearish | 72.00 | 0.38 | 70.62 | - | 1.23 | - | 28.93 |
| Vivo Bio Tech | Bearish | 33.49 | 0.39 | 71.79 | 7.70 | 0.7 | - | 44.85 |
| Biofil Chemicals And Pharma | Bearish | 39.00 | -1.86 | 63.85 | 135.94 | 4 | - | - |
| Vista Pharmaceuticals | Bearish | 9.74 | 5.18 | 60.68 | - | 0.31 | - | 5.24 |
- Promoter(s) holding is moderate at 46.79%
- Promoter(s) have decreased the stake in the company in last 12 months
- FIIs are not invested in this company
- Mutual Funds are not invested in this company.
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-11-13 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-30 | Audited Results |
| 2025-02-11 | Quarterly Results & Others |
| 2024-11-14 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE829A01014
- BSE Code524396
- NSE CodeBIOFILCHEM
Biofil Chemicals and Pharmaceuticals is trading at 39.00 as on Fri Nov 14 2025 09:59:50. This is -1.86% lower as compared to its previous closing price of 39.74.
The market capitalization of Biofil Chemicals and Pharmaceuticals is 63.85 Cr as on Fri Nov 14 2025 09:59:50.
The 52 wk high for Biofil Chemicals and Pharmaceuticals is 72.00 whereas the 52 wk low is 38.00
Biofil Chemicals and Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: 27.46
- Sector P/E: 30.99
- Dividend Yield: 0.00%
- D/E ratio: -
Biofil Chemicals and Pharmaceuticals reported a net profit of 0.56 Cr in 2025.
EQUITY QUICK LINKS
Biofil Chemicals and Pharmaceuticals QUICK LINKS
- Biofil Chemicals and Pharmaceuticals Dividend
- Biofil Chemicals and Pharmaceuticals Bonus
- Biofil Chemicals and Pharmaceuticals News
- Biofil Chemicals and Pharmaceuticals AGM
- Biofil Chemicals and Pharmaceuticals Rights
- Biofil Chemicals and Pharmaceuticals Splits
- Biofil Chemicals and Pharmaceuticals Board Meetings